Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,510.00
+57.20 (3.94%)
Sep 11, 2026, 3:29 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 157.52 billion as of September 11, 2026. Its market cap has decreased by -9.85% in one year.
Market Cap
157.52B
Enterprise Value
153.21B
Revenue
11.08B
Ranking
n/a
PE Ratio
57.39
Stock Price
1,510.00
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 157.52B, an increase of 59.71%. That is a compound annual growth rate of 16.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 157.52B | 11.90% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 634.28B |
| Anthem Biosciences | 530.70B |
| OneSource Specialty Pharma | 176.77B |
| Blue Jet Healthcare | 108.89B |
| Supriya Lifescience | 73.84B |
| Zota Health Care | 38.59B |
| Dishman Carbogen Amcis | 26.75B |
| Panacea Biotec | 23.81B |